眾興菌業(002772.SZ):2個募投項目結項
格隆匯3月23日丨眾興菌業(002772.SZ)公佈,公司於2022年3月23日召開第四屆董事會第十二次會議及第四屆監事會第六次會議審議通過了《關於部分募集資金投資項目結項並將節餘募集資金永久性補充流動資金的議案》,鑑於公司可轉換公司債券募集資金投資項目安陽眾興菌業科技有限公司(“安陽眾興”)“年產2萬噸雙孢蘑菇及11萬噸堆肥工廠化生產項目”及武威眾興菌業科技有限公司(“武威眾興”)“年產32400噸金針菇工廠化循環經濟產業鏈建設項目”已建成投產,董事會同意將上述兩項目予以結項。
同時,為提高募集資金使用效率,結合公司實際經營情況,公司擬將上述募投項目結項後的節餘募集資金16791.16萬元(含利息及尚未支付的504.7萬元工程尾款/質保金,實際金額以資金轉出當日專户餘額為準。)永久性補充流動資金,用於公司日常經營及業務發展。該事項尚需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.